Lamitor Dt 25mg 15 Tablets

Babies: It does not apply to babies. Lactating mothers: Lamogtrigine is not recommended in breastfeeding women because it is excreted in milk. However, consult your doctor if the benefits outweigh the risk your doctor may prescribe the medication. Pregnancy: Lamitor should not be used during pregnancy because it may harm the fetus.
This medication should be used only when necessary during pregnancy. Consult your doctor about the risks and benefits. Driving: Lamitor capsule may impair your alertness, impair your vision, or make you sleepy and dizzy.
If you experience any of these symptoms, do not drive. Alcohol: Avoid alcohol consumption while taking lamitor hcl capsules as it may increase the risk of drowsiness and dizziness. Liver: Lamitor capsule should be used in caution with patients suffering from liver disease. You may require a dose adjustment and regular monitoring of liver function.
Seek doctor advice before using this medication. Kidney: Lamitor capsules should be used in caution with patients suffering from kidney disease.
You may require a dose adjustment and regular monitoring of kidney function. Seek doctor advice before using this medication.
.

Blurred vision Double vision Loss of coordination Skin Rash Anxiety Depressed mood Confusion Swelling of face, lips, eyelids, tongue, hands and feet Flu-Like symptoms Headache Nausea or vomiting Diarrhoea Running nose.

Lamitor capsule is an anticonvulsant. It works by reducing abnormal and excessive nerve cell activity in the brain..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• It can make you dizzy and sleepy. Do not drive or engage in any activity that requires mental focus until you have determined how it affects you. • It has the potential to cause headaches.
Drink plenty of water and take a pain reliever as directed. If it does not go away, consult your doctor. • It has the potential to cause a skin rash.
Notify your doctor right away if you notice a rash, itching, or skin peeling. • Consult your doctor if you experience sudden mood swings or suicidal thoughts. • Do not abruptly discontinue the medication without first consulting your doctor, as this may increase the frequency of seizures..

Serious • Lamitor + Atazanavir: Concurrent use may lead to decreased lamitor serum concentrations • Lamitor + Calciferol: Concurrent use may lead to altered serum levels of calciferol • Lamitor + Carbamazepine: Concurrent use may lead to decreased lamitor efficacy. • Lamitor + Cenobamate: Concurrent use may lead to decreased lamitor concentrations and lamitor efficacy • Lamitor + Desmopressin: Concurrent use may lead to increased risk of hyponatremia • Lamitor + Divalproex sodium: Concurrent use may lead to increased lamitor exposure and increased risk of severe, potentially life-threatening rash • Lamitor + Dofilide: Concurrent use may lead to increased plasma levels of oct2 substrates with narrow therapeutic index. • Lamitor + Ezogabine: Concurrent use may lead to decreased lamitor plasma concentration. • Lamitor + Fsphenytoin: Concurrent use may lead to decreased lamitor efficacy • Lamitor + Lopinavir: Concurrent use may lead to decreased lamitor exposure • Lamitor + Orlistat: Concurrent use may lead to decreased anticonvulsant effictiveness • Lamitor + Phenobarbital: Concurrent use may lead to decreased lamitor efficacy • Lamitor + Primidone: Concurrent use may lead to decreased lamitor efficacy • Lamitor + Rifampin: Concurrent use may lead to decreased lamitor exposure • Lamitor + Valproate sodium: Concurrent use may lead to increased risk of lamitor exposure and increased risk of severe, potentially life threatening rash • Lamitor + Valproic acid: Concurrent use may lead to increased risk of lamitor exposure and increased risk of severe, potentially life threatening rash Monitor closely • Lamitor + Chinese gingseng root: Concurrent use may lead to increased risk of drug interaction with eosinophilia and systemic symptoms syndrome • Lamitor + Desogestral: Concurrent use may lead to decreased lamitor plasma concentrations • Lamitor + Dienogest: Concurrent use may lead to decreased lamitor plasma concentrations • Lamitor + Drospirenone: Concurrent use may lead to decreased lamitor plasma concentrations • Lamitor + Escitalopram: Concurrent use may lead to increased risk of myoclonus • Lamitor + Estetrol: Concurrent use may lead to decreased lamitor plasma concentrations • Lamitor + Estradiol: Concurrent use may lead to decreased lamitor plasma concentrations • Lamitor + Ethynodiol: Concurrent use may lead to decreased lamitor plasma concentrations • Lamitor + Evening primrose: Concurrent use may lead to decreased anticonvulsant effectiveness • Lamitor + Gestodene: Concurrent use may lead to decreased lamitor plasma concentrations • Lamitor + Ritonavir: Concurrent use may lead to decreased lamitor plasma concentrations • Lamitor + Oxcarbazepine: Concurrent use may lead to decreased lamitor plasma concentrations and possible loss of seizure control Minor • Lamitor + Acetaminophen: Concurrent use may lead to decreased lamitor effectiveness.